Funds and prices
Overview
Very actively managed equity fund. The portfolio is primarily focused on securities from large companies though strategically supplemented by securities from small and medium-sized companies.
The fund manager is given great flexibility to take focused views on the most attractive stocks and exploit the best opportunities, unconstrained by the reference index.
The fund offers investors a broader diversification compared to the index including lower maximum single stock weights (max. 10%) and a more balanced sector allocation.
The portfolio manager is not tied to the benchmark in terms of investment selection or weight.
Benefits
The fund draws on the knowledge of proven investment specialists based in Zurich (Switzerland).
Due to the significant deviation from the reference index, the fund offers the potential to outperform the reference index.
ÃÛ¶¹ÊÓÆµ's proprietary fundamental valuation approach allows consistent selection of attractive Swiss companies.
Investors benefit from a global investment platform of ÃÛ¶¹ÊÓÆµ Asset Management.
Risks
Features
Product category |
ÃÛ¶¹ÊÓÆµ Equity Funds
ÃÛ¶¹ÊÓÆµ Opportunity Equity Funds |
Product domicile |
Luxembourg
|
Portfolio management |
ÃÛ¶¹ÊÓÆµ Asset Management Switzerland AG, Zurich
|
Fund management |
ÃÛ¶¹ÊÓÆµ Fund Management (Luxembourg) S.A., Luxembourg
|
Custodian bank |
ÃÛ¶¹ÊÓÆµ Europe SE, Luxembourg Branch
|
Representative for products established under foreign law |
ÃÛ¶¹ÊÓÆµ Asset Management (UK) Limited
|
Day of inception |
08 September 2015
|
Currency of account |
CHF
|
Close of financial year |
31 May
|
Issue / redemption |
daily
|
Distribution |
Reinvestment
|
Maturity |
Open end
|
Management fee |
0.82% p.a.
|
Total expense ratio (TER) |
1.08% p.a.
|
Swing pricing |
yes
|
Minimum investment |
n.a.
|
Reference Index / Benchmark |
SPI® (TR)
|
ISIN |
LU1240788148
|
Bloomberg Ticker |
ÃÛ¶¹ÊÓÆµSCQA LX
|
Performance and Prices
Percentage growth
as of 03 April 2024CHF(%) | EUR(%) | |
YTD | ||
1M | ||
3M | 5.24 | -0.19 |
6M | 7.58 | 5.89 |
1Y | 1.63 | 3.03 |
2Y | -4.59 | -0.53 |
3Y | 1.23 | 14.55 |
5Y | ||
ø p.a.5Y | 4.36 | 7.17 |
CHF(%) | EUR(%) | |
Q1 2023 to Q1 2024 | 2.39 | 4.48 |
Q1 2022 to Q1 2023 | -5.68 | -2.70 |
Q1 2021 to Q1 2022 | 7.01 | 15.61 |
Q1 2020 to Q1 2021 | 26.50 | 21.41 |
Q1 2019 to Q1 2020 | -2.56 | 2.64 |
Current data
Net asset value | 03.04.2024 | CHF 163.65 |
High - last 12 months | 08.05.2023 | CHF 167.39 |
Low - last 12 months | 27.10.2023 | CHF 145.41 |
Assets of the unit class in mn | 03.04.2024 | CHF 7.55 |
Total product assets in mn | 03.04.2024 | CHF 51.77 |
Date
|
2 years
|
5 years
|
|
Total risk reference index / benchmark | 29.02.2024 | 12.60% | 12.59% |
Sharpe Ratio | 29.02.2024 | -0.25 | 0.33 |
Risk Free Rate | 31.03.2024 | 0.87% | -0.06% |
Structures
By the 10 largest equity positions (in %, as of 29 February 2024)
|
|
Roche Holding AG | 9.62 |
Novartis AG | 9.41 |
Nestle SA | 9.12 |
Zurich Insurance Group AG | 7.69 |
Swiss Re AG | 5.11 |
ABB Ltd | 5.10 |
ÃÛ¶¹ÊÓÆµ Group AG | 4.83 |
Lonza Group AG | 4.09 |
Swiss Life Holding AG | 3.74 |
Cie Financiere Richemont SA | 3.15 |
Fees
Distributions
Authorisations
Literature
Document type
|
Document Language
|
Prospectus |
|
Country supplement |
|
Key Investor Information (KIID) |
|
Past performance |
|
Previous performance scenario |
|
ESG Disclosure |
|
Document type
|
Document Language
|
Annual report |
|
Semi-annual report |
|